Mobix Labs, Inc: Form 10-Q for the period ended Mar 31, 2026
Filed with the SEC on May 20, 2026 and accepted by EDGAR at May 20, 2026, 21:12 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2026-01-01 to 2026-03-31 | $970.0k | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2025-10-01 to 2026-03-31 | $2.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2026-01-01 to 2026-03-31 | $786.0k | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2025-10-01 to 2026-03-31 | $2.1m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2026-01-01 to 2026-03-31 | $184.0k | us-gaap:GrossProfit |
| Gross profit | 6 months2025-10-01 to 2026-03-31 | $765.0k | us-gaap:GrossProfit |
| Research and development | 3 months2026-01-01 to 2026-03-31 | $428.0k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2025-10-01 to 2026-03-31 | $870.0k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2026-01-01 to 2026-03-31 | $5.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2025-10-01 to 2026-03-31 | $14.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2026-01-01 to 2026-03-31 | −$6.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2025-10-01 to 2026-03-31 | −$14.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2026-01-01 to 2026-03-31 | $1.4m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 6 months2025-10-01 to 2026-03-31 | $2.8m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2026-01-01 to 2026-03-31 | $3.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2025-10-01 to 2026-03-31 | −$21.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-01-01 to 2026-03-31 | −$5.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months2025-10-01 to 2026-03-31 | −$16.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-01-01 to 2026-03-31 | −$0.59 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2025-10-01 to 2026-03-31 | −$1.98 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-01-01 to 2026-03-31 | −$0.59 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2025-10-01 to 2026-03-31 | −$1.98 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-01-01 to 2026-03-31 | 9,838,724 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2025-10-01 to 2026-03-31 | 8,058,263 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2025-10-01 to 2026-03-31 | −$9.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2026-03-31 | $2.6m | us-gaap:Cash |
| Current assets | At period end2026-03-31 | $5.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2026-03-31 | $34.9m | us-gaap:Assets |
| Current liabilities | At period end2026-03-31 | $24.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2026-03-31 | $26.0m | us-gaap:Liabilities |
| Long-term debt | At period end2026-03-31 | $1.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2026-03-31 | $5.4m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2026-03-31 | $8.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-26-024661. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.